CORRESPONDENCE
Authors:
- B.G. TaalBTB.G. Taal
- H. ZuetenhorstHZH. Zuetenhorst
- R.A. Valdes OlmosROR.A. Valdes Olmos
- C.A. HoefnagelCHC.A. Hoefnagel
- 1 April 2002
- journal article
- editorial
- Published by Elsevier in European Journal of Surgical Oncology
- Vol. 28 (3) , 243
Abstract
No abstract availableThis publication has 5 references indexed in Scilit:
- 131I-MIBG radionuclide therapy is safe and cost-effective in the control of symptoms of the carcinoid syndromeEuropean Journal of Surgical Oncology, 2001
- Improved effect of 131I-MIBG treatment by predosing with non-radiolabeled MIBG in carcinoid patients, and studies in xenografted miceAnnals of Oncology, 2000
- Enhancement of 131I-MIBG uptake in carcinoid tumours by administration of unlabelled MIBGNuclear Medicine Communications, 2000
- Long-term palliation in metastatic carcinoid tumours with various applications of meta-iodobenzylguanidin (MIBG)European Journal of Gastroenterology & Hepatology, 1999
- Palliative effect of metaiodobenzylguanidine in metastatic carcinoid tumors.Journal of Clinical Oncology, 1996